Humedix Co., Ltd. (200670.KQ)

KRW 42800.0

(3.38%)

Market Cap (In KRW)

441.21 Billion

Revenue (In KRW)

152.27 Billion

Net Income (In KRW)

24.82 Billion

Avg. Volume

110.15 Thousand

Currency
KRW
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
25400.0-43950.0
PE
-
EPS
-
Beta Value
0.611
ISIN
KR7200670008
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Jin-hwan Kim
Employee Count
-
Website
http://www.humedix.com
Ipo Date
2014-12-26
Details
Humedix Co., Ltd., a healthcare company, researches, develops, manufactures, and sells various pharmaceutical products in South Korea. It offers over-the-counter drugs, prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic products, and functional synthetic materials, as well as health functional foods. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. The company was founded in 2002 and is headquartered in Anyang-si, South Korea.